药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Magnesium oxide
Clenbuterol
Clenbuterol may decrease the antihypertensive activities of Levamlodipine.
Magnesium oxide
Methotrimeprazine
Methotrimeprazine may decrease the antihypertensive activities of Levamlodipine.
Magnesium oxide
Yohimbine
Yohimbine may decrease the antihypertensive activities of Levamlodipine.
Magnesium oxide
Obinutuzumab
Levamlodipine may increase the hypotensive activities of Obinutuzumab.
Magnesium oxide
Dexmethylphenidate
Dexmethylphenidate may decrease the antihypertensive activities of Levamlodipine.
Aluminium monostearate
Satralizumab
The serum concentration of Dexibuprofen can be decreased when it is combined with Satralizumab.
Aluminium monostearate
Selpercatinib
The serum concentration of Selpercatinib can be increased when it is combined with Dexibuprofen.
Aluminium monostearate
Alpelisib
The serum concentration of Dexibuprofen can be decreased when it is combined with Alpelisib.
Aluminium monostearate
Relcovaptan
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Relcovaptan.
Aluminium monostearate
Buflomedil
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Buflomedil.
Aluminium monostearate
Linsidomine
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Linsidomine.
Aluminium monostearate
Cloricromen
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Cloricromen.
Aluminium monostearate
Picotamide
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Picotamide.
Aluminium monostearate
Ramatroban
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Ramatroban.
Aluminium monostearate
Hydroxytyrosol
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Hydroxytyrosol.
Aluminium monostearate
Butylphthalide
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Butylphthalide.
Aluminium monostearate
Ketanserin
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Ketanserin.
Aluminium monostearate
Ifetroban
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Ifetroban.
Aluminium monostearate
Sarpogrelate
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Sarpogrelate.
Aluminium monostearate
Naftopidil
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Naftopidil.